【MDC】Electronic Arthroscope EJA100 Approved by Taiwan Food and Drug Administration (TFDA)

MDC announced that its electronic arthroscope EJA100 has passed the TFDA Class II medical device review in Taiwan.
新製品NQ 87/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 22, 2026 at 09:00
  • 🔍 Collected: May 23, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 24, 2026 at 07:06 (23h 6m after Collected)
1. Date of occurrence: May 22, 115 (Republic of China Calendar)
2. Company name: Micro-Electronic Technologies Inc. (MDC)
3. Relationship with the company: The Company
4. Mutual shareholding ratio: Not applicable
5. Reason for occurrence: The Company's electronic arthroscope EJA100 has passed the Class II medical device review by the Taiwan Food and Drug Administration (TFDA) (Registration No. Wei-Bu-Yi-Qi-Zhi-Zi No. 008782).
6. Response measures: None.
7. Other matters to be noted (If the subject of the event or resolution belongs to a public company or above, this material information is also compliant with Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act regarding matters that have a material impact on shareholders' equity or securities prices):
The "MDC" Heros electronic arthroscope and its accessories are sterile, single-use medical devices that must be used with a compatible display system. This device is intended for diagnostic and surgical arthroscopy or endoscopy procedures, providing imaging of internal cavities through surgical incisions. This device is for use in hospitals or medical institutions and is indicated for adults.
This disposable product not only saves time on instrument sterilization but also helps improve medical quality and reduces the risk of cross-infection.

FAQ

What is the EJA100 electronic arthroscope by MDC?

It is a sterile, single-use medical device used for diagnostic and surgical arthroscopy or endoscopy procedures in adults.

What are the key benefits of the EJA100?

Being a single-use product, it eliminates the need for instrument sterilization, improves surgical efficiency, and reduces the risk of cross-infection.

Which regulatory body granted the approval?

It was approved by the Taiwan Food and Drug Administration (TFDA) of the Ministry of Health and Welfare.